abstract |
Disclosed herein are methods of treatments with a telomerase-mediated telomere-targeting drug, 6-thio-2 ' -deoxyguanosine (6-thio-dG), checkpoint inhibitors and/or radiation therapy for treating cancers, eads to tumor regression in innate and adaptive immune-dependent manners in syngeneic and humanized mouse cancer models. |